论文部分内容阅读
目的探讨大环内酯类药物治疗小儿支原体感染的临床疗效效果。方法选取在本院进行治疗的支原体肺炎的患者128例,随机分为对照组和治疗组,对照组采用红霉素进行治疗,治疗组采用阿奇霉素进行治疗,治疗1个月后,观察两组患者的临床疗效。结果治疗组的总有效率为89.06%明显高于对照组的79.69%(P<0.05),治疗组的胃肠反应不良反应率为14.06%明显低于对照组的26.56%(P<0.05)。结论采用大环内酯类药物阿奇霉素治疗小儿支原体感染,取得了较好的临床疗效,值的在临床上推广使用。
Objective To investigate the clinical efficacy of macrolides in the treatment of Mycoplasma infection in children. Methods 128 cases of mycoplasma pneumonia treated in our hospital were randomly divided into the control group and the treatment group. The control group was treated with erythromycin. The treatment group was treated with azithromycin. After 1 month of treatment, the patients in both groups were observed The clinical efficacy. Results The total effective rate of the treatment group was 89.06%, which was significantly higher than that of the control group (79.69%, P <0.05). The adverse reaction rate of the treatment group was 14.06%, which was significantly lower than that of the control group (26.56%, P <0.05). Conclusion The use of macrolide azithromycin treatment of children with mycoplasma infection, and achieved good clinical efficacy, the value of the clinical use.